Technical analysis of Oaktree Acquisition Corp. II (OACC): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
Price Performance
| 1 month | +0.09% |
| 3 months | +1.22% |
| Year-to-date | +1.89% |
| 1 year | +2.96% |
52-Week Range
| 52-week High | $10.88 |
| 52-week Low | $10.44 |
| Avg Volume (90d) | 22K |
Technical Indicators
| SMA 50 | $10.75 |
| SMA 200 | $10.67 |
| Beta | -0.04 |
| 30-day Volatility (annualised) | 2.8% |
| Price vs SMA 50 | +0.3% |
| Price vs SMA 200 | +1.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $10.58 | |
| 2025-11 | $10.56 | -0.2% |
| 2025-12 | $10.58 | +0.2% |
| 2026-01 | $10.65 | +0.7% |
| 2026-02 | $10.70 | +0.5% |
| 2026-03 | $10.58 | -1.1% |
| 2026-04 | $10.61 | +0.3% |
| 2026-05 | $10.68 | +0.7% |
| 2026-06 | $10.70 | +0.2% |
| 2026-07 | $10.74 | +0.4% |
| 2026-08 | $10.76 | +0.2% |
| 2026-09 | $10.78 | +0.2% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $0.10 | $84M |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | $0.03 | $3M |
| 2026-09-14 | | |
| 2026-09-14 | $-0.26 | $14M |
Price
| Price | $10.78 |
| Market Cap | $265M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 38.12 |
| Price / Book | 1.05 |
| EV / EBITDA | -220.35 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 0.73 |